---
title: "Our Technologies"
id: "194"
type: "page"
slug: "technologies"
published_at: "2025-07-09T14:23:04+00:00"
modified_at: "2026-07-21T14:07:46+00:00"
url: "https://innocorepharma.com/technologies/"
markdown_url: "https://innocorepharma.com/technologies.md"
---

Technologies

# Enabling stable, scalable long-acting injectable formulations for complex biologics and peptides

Innocore is the leading drug delivery development provider of long-acting injectable dosage forms of peptides and complex biologics based on its proprietary, best-in-class polymeric drug delivery platform, SynBiosys®.

SynBiosys® can overcome the significant technical challenges of translating complex and fragile APIs into stable, tunable and scalable LAI drug products whilst maintaining the essential bioactive characteristics of the API, from peptides and biologics, to oligonucleotides or antibody drug conjugates (ADC).

[Microphere Technology & Manufacturing – Innocore Fewer doses, better control with InnoCore monodispersed microspheres. Discover more](https://innocorepharma.com/technologies/microspheres/)
[Biodegradable implants – Innocore Biodegradable implants - versatile, precise, and long-lasting. Discover more](https://innocorepharma.com/technologies/implants/)
[In Situ Depot Formulation & Drug Development – Innocore In-situ forming depots - easy to make, designed to last. Discover more](https://innocorepharma.com/technologies/in-situ-forming-depots/)
[SynBiosys® Biodegradable Polymer – Innocore Versatile polymer platform preserving the bioactivity of peptides and biologics. Discover more](https://innocorepharma.com/technologies/synbiosys/)